MeiraGTx (MGTX)
(Delayed Data from NSDQ)
$5.29 USD
+0.15 (2.82%)
Updated May 24, 2024 04:00 PM ET
After-Market: $5.29 +0.01 (0.09%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MGTX 5.29 +0.15(2.82%)
Will MGTX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MGTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGTX
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates
MGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates
Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?
Wall Street Analysts Think MeiraGTx Holdings PLC (MGTX) Could Surge 217.92%: Read This Before Placing a Bet
Other News for MGTX
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
Meiragtx Holdings (MGTX) Gets a Buy from Piper Sandler
Meiragtx Holdings (MGTX) Receives a Buy from RBC Capital
MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q1 2024